This is the authors' abstract. We don't add key points for this paper.
THE isolation of the hypophyseal growth hormone in a pure form by Li, Evans and Simpson (1) has made possible the use of the purified hormone in clinical experiments. This pure hormone was first administered in the spring of 1947 to a girl judged clinically to be a hypopituitary dwarf. At a dose level approaching 5 milligrams per kilogram of body weight it was without effect upon nitrogen balance. It is the purpose of this paper to report these balance studies: the complete long-term study of the patient which includes the administration of growth hormone for four months will be reported subsequently. The patient (F. H.) was a girl, aged 16½ years, with a bone age of 13 years and dental age of 1.2 years. She weighed 70½ lbs. (32 Kg.), was 49.8 inches (127 cm.) in height, and had an I.Q. of 130. Her early development was said to have been normal; retarded growth was first apparent at the age of 5. After the age of 12 years she had grown approximately one inch in height, no gain in height having occurred in the two and one-half years prior to this study. Previous therapy with thyroid by mouth, injections of crude anterior pituitary extracts, and implantation of two calves' anterior pituitaries into her broad ligament had been without effect upon her growth rate.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Bennett et al. (1950) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: